OTCMKTS:HYYDF

Hexo Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range

$5.30

MA: $5.30▼

$5.30

52-Week Range N/A

Volume1.40 million shs

Average Volume773,571 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

HEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:HYYDF

Previous Symbol

CUSIPN/A

CIKN/A

Webthehydropothecary.com

Phone(844) 406-1852

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Headlines

Will HEXO's "Bake Sale" Ruin Its Chances of Posting a Profit? - Motley Fool
April 13, 2021 | fool.com

Hexo (OTCMKTS:HYYDF) Trading Up 1.8%
April 13, 2021 | americanbankingnews.com

Zenabis Announces Receipt of Interim Order for Proposed Arrangement with HEXO Corp. - Yahoo Finance
April 7, 2021 | finance.yahoo.com

2 Marijuana Stocks To Watch This Week As The Cannabis Sector Slowly Recovers - StreetInsider.com
April 5, 2021 | streetinsider.com

1 Pot Stock That Every Cannabis Investor Should Own - Yahoo Canada Finance
March 29, 2021 | ca.finance.yahoo.com

Hexo: Positive Developments Boost the Bull Case, Says Analyst - Nasdaq
March 25, 2021 | nasdaq.com

Hexo (OTCMKTS:HYYDF) Shares Up 1.8%
March 23, 2021 | americanbankingnews.com

Hexo (TSX:HEXO) Stock Soars 9% as Revenue Nearly Doubled in Q2 - The Motley Fool Canada
March 19, 2021 | fool.ca

Looking for Parabolic Growth? Hexo Stock Is a Winner - The Motley Fool Canada
March 19, 2021 | fool.ca

Hexo reports $20.8-million loss in second quarter, revenue nearly doubled compared with year ago - The Globe and Mail
March 18, 2021 | theglobeandmail.com

HEXO Corp announces positive adjusted EBITDA and 94% increase in net revenue from prior year - Yahoo Finance
March 18, 2021 | finance.yahoo.com

Why HEXO Corp (HEXO) Might Surprise This Earnings Season - Yahoo Finance
March 16, 2021 | finance.yahoo.com

Why These Marijuana Stocks Blasted Higher Today - Motley Fool
March 11, 2021 | fool.com

HEXO (TSX:HEXO) Stock at $10: Will Shares Double Again? - The Motley Fool Canada
February 28, 2021 | fool.ca

Canopy, Hexo and Aphria down after Cronos’ Q4 earnings falls short of consensus - Seeking Alpha
February 26, 2021 | seekingalpha.com

5 Pot Stocks Money Managers Bought Hand Over Fist in Q4 - Motley Fool
February 24, 2021 | fool.com

2 Growth Stocks to Buy and Hold Until 2024 - The Motley Fool Canada
February 21, 2021 | fool.ca

Hexo Makes Opportunistic Purchase in Canadian Cannabis Market - InvestorPlace
February 18, 2021 | investorplace.com

CIBC sees HEXO bull case post acquisition, upgrades shares - Seeking Alpha
February 17, 2021 | seekingalpha.com

Want to Play US Cannabis Legalization? Hexo Stock Is a Great Option - Investorplace.com
February 11, 2021 | investorplace.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.60 out of 5 stars

Medical Sector

1381st out of 2,019 stocks

Drug Manufacturers - Specialty & Generic Industry

28th out of 61 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Hexo.

3.0 Community Rank

Outperform Votes
Hexo has received 39 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Hexo has received 25 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Hexo has received 60.94% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Hexo and other stocks. Vote “Outperform” if you believe HYYDF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HYYDF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Hexo does not currently pay a dividend.
Dividend Growth
Hexo does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hexo insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

30 days | 90 days | 365 days | Advanced Chart

Receive HYYDF News and Ratings via Email

Sign-up to receive the latest news and ratings for HYYDF and its competitors with MarketBeat's FREE daily newsletter.

Hexo (OTCMKTS:HYYDF) Frequently Asked Questions

What stocks does MarketBeat like better than Hexo?

Wall Street analysts have given Hexo a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Hexo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Hexo's key executives?

Hexo's management team includes the following people:

Michael Munzar, Chairman & Medical Director
Sébastien St. Louis, President, Chief Executive Officer & Director
Donald J. Courtney, Chief Operating Officer
Stephen Burwash, Chief Financial Officer
MAx Cyr, Director-Customer Experience & Compliance

Who are some of Hexo's key competitors?

Some companies that are related to Hexo include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of HYYDF's competitors.

What is Hexo's stock symbol?

Hexo trades on the OTCMKTS under the ticker symbol "HYYDF."

How do I buy shares of Hexo?

Shares of HYYDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hexo's official website?

The official website for Hexo is thehydropothecary.com.

How can I contact Hexo?

The company can be reached via phone at (844) 406-1852.

This page was last updated on 4/14/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Hexo Stock Forecast, Price & News

Adding

Adding

Adding Hexo Corp

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Headlines

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

3.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth